INSPIRE MEDICAL SYSTEMS INC (INSP) Stock Analyst Earnings Estimates
NYSE:INSP - New York Stock Exchange, Inc. - US4577301090 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 233.4M 102.25% | 407.9M 74.76% | 624.799M 53.17% | 812.01M 29.96% | 970.28M 19.49% | 1.143B 17.80% | 1.336B 16.89% | 1.539B 15.19% | 1.737B 12.87% | 1.962B 12.95% | 2.104B 7.24% | 2.395B 13.83% | |
| EBITDA YoY % growth | -38.68M 30.13% | -45.74M -18.25% | -37.425M 18.18% | 17.479M 146.70% | 62.833M 259.48% | 120.75M 92.18% | 277.34M 129.68% | 342.21M 23.39% | 407.29M 19.02% | 479.5M 17.73% | 564.47M 17.72% | N/A | |
| EBIT YoY % growth | -39.9M 29.00% | -47.6M -19.30% | -40.271M 15.40% | 20.803M 151.66% | 49.319M 137.08% | 98.704M 100.13% | 162.15M 64.28% | 218.31M 34.63% | 303.01M 38.80% | 368.36M 21.57% | 447.07M 21.37% | 631.38M 41.23% | |
| Operating Margin | -17.10% | -11.67% | -6.45% | 2.56% | 5.08% | 8.64% | 12.14% | 14.19% | 17.44% | 18.77% | 21.25% | 26.36% | |
| EPS YoY % growth | -1.55 30.18% | -1.64 -5.81% | -0.74 54.88% | 1.35 282.55% | 2.04 50.66% | 3.24 59.36% | 3.90 20.21% | 5.42 38.91% | 7.09 30.95% | 8.90 25.50% | 8.48 -4.78% | N/A |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.73 49.64% | -0.11 67.86% | 0.44 38.43% | 0.58 -3.71% | 1.05 43.60% | 0.49 548.01% | 0.57 28.95% | 0.61 5.93% | 0.69 -34.13% |
| Revenue Q2Q % growth | 237.95M 23.61% | 203.75M 24.23% | 236.82M 20.90% | 244.24M 20.20% | 283.8M 19.27% | 248.3M 21.87% | 281.43M 18.84% | 287.67M 17.78% | 314.15M 10.69% |
| EBITDA Q2Q % growth | 26.207M 115.82% | -6.408M 55.44% | 15.049M 105.56% | 21.222M 15.40% | 39.355M 50.17% | 8.69M 235.62% | 12.413M -17.52% | 14.647M -30.98% | 16.85M -57.18% |
| EBIT Q2Q % growth | 18.596M 100.02% | -8.912M 41.44% | 9.397M 84.29% | 14.79M 3.30% | 29.727M 59.86% | 6.701M 175.19% | 9.282M -1.22% | 10.934M -26.07% | 13.505M -54.57% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 0.60 306.90% | 0.08 | 0.52 | 681.29% |
| Q2 2024 Q2Q % growth | 0.32 178.05% | -0.14 | 0.46 | 325.04% |
| Q1 2024 Q2Q % growth | -0.34 35.85% | -0.66 | 0.32 | 48.86% |
| Q4 2023 Q2Q % growth | 0.49 390.00% | -0.09 | 0.58 | 642.33% |
| Q3 2023 Q2Q % growth | -0.29 51.67% | -0.59 | 0.30 | 51.01% |
| Q2 2023 Q2Q % growth | -0.41 22.64% | -0.58 | 0.17 | 29.39% |
| Q1 2023 Q2Q % growth | -0.53 13.11% | -0.67 | 0.14 | 21.27% |
| Q4 2022 Q2Q % growth | 0.10 211.11% | -0.58 | 0.68 | 117.32% |
| Q3 2022 Q2Q % growth | -0.60 -57.89% | -0.78 | 0.18 | 23.21% |
| Q2 2022 Q2Q % growth | -0.53 -10.42% | -0.63 | 0.10 | 15.95% |
| Q1 2022 Q2Q % growth | -0.61 -1.67% | -0.81 | 0.20 | 24.87% |
| Q4 2021 Q2Q % growth | -0.09 67.86% | -0.45 | 0.36 | 79.81% |
| Q3 2021 Q2Q % growth | -0.38 2.56% | -0.63 | 0.25 | 39.38% |
| Q2 2021 Q2Q % growth | -0.48 45.45% | -0.65 | 0.17 | 26.57% |
| Q1 2021 Q2Q % growth | -0.60 10.45% | -0.67 | 0.07 | 10.87% |
| Q4 2020 Q2Q % growth | -0.28 26.32% | -0.49 | 0.21 | 43.08% |
| Q3 2020 Q2Q % growth | -0.39 -14.71% | -0.74 | 0.35 | 47.01% |
| Q2 2020 Q2Q % growth | -0.88 -175.00% | -1.12 | 0.24 | 21.57% |
| Q1 2020 Q2Q % growth | -0.67 -91.43% | -0.58 | -0.09 | -15.89% |
| Q4 2019 Q2Q % growth | -0.38 | -0.41 | 0.03 | 7.21% |
| Q3 2019 Q2Q % growth | -0.34 | -0.42 | 0.08 | 19.26% |
| Q2 2019 Q2Q % growth | -0.32 | -0.44 | 0.12 | 27.62% |
| Q1 2019 Q2Q % growth | -0.35 | -0.39 | 0.04 | 9.97% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 203.191M 32.54% | 201.55M | 1.641M | 0.81% |
| Q2 2024 Q2Q % growth | 195.885M 29.65% | 193.25M | 2.635M | 1.36% |
| Q1 2024 Q2Q % growth | 164.01M 28.24% | 164.67M | -660K | -0.40% |
| Q4 2023 Q2Q % growth | 192.508M 39.60% | 190.98M | 1.528M | 0.80% |
| Q3 2023 Q2Q % growth | 153.302M 40.39% | 157.54M | -4.238M | -2.69% |
| Q2 2023 Q2Q % growth | 151.092M 65.31% | 139.07M | 12.022M | 8.64% |
| Q1 2023 Q2Q % growth | 127.897M 84.29% | 121.69M | 6.207M | 5.10% |
| Q4 2022 Q2Q % growth | 137.9M 75.89% | 131.85M | 6.05M | 4.59% |
| Q3 2022 Q2Q % growth | 109.2M 76.99% | 96.201M | 12.999M | 13.51% |
| Q2 2022 Q2Q % growth | 91.4M 72.45% | 79.841M | 11.559M | 14.48% |
| Q1 2022 Q2Q % growth | 69.4M 71.78% | 65.454M | 3.946M | 6.03% |
| Q4 2021 Q2Q % growth | 78.4M 70.43% | 78.117M | 283K | 0.36% |
| Q3 2021 Q2Q % growth | 61.7M 72.35% | 56.725M | 4.975M | 8.77% |
| Q2 2021 Q2Q % growth | 53M 334.43% | 44.747M | 8.253M | 18.44% |
| Q1 2021 Q2Q % growth | 40.4M 89.67% | 37.678M | 2.722M | 7.22% |
| Q4 2020 Q2Q % growth | 46M 71.00% | 41.895M | 4.105M | 9.80% |
| Q3 2020 Q2Q % growth | 35.8M 71.29% | 23.203M | 12.597M | 54.29% |
| Q2 2020 Q2Q % growth | 12.2M -32.22% | 8.009M | 4.191M | 52.33% |
| Q1 2020 Q2Q % growth | 21.3M 30.67% | 21.688M | -388K | -1.79% |
| Q4 2019 Q2Q % growth | 26.9M | 24.32M | 2.58M | 10.61% |
| Q3 2019 Q2Q % growth | 20.9M | 19.561M | 1.339M | 6.85% |
| Q2 2019 Q2Q % growth | 18M | 17.008M | 992K | 5.83% |
| Q1 2019 Q2Q % growth | 16.3M | 15.294M | 1.006M | 6.58% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 13.68% | 0% | 78.26% |
| Revenue | 0% | -3.04% | 0% | 0.12% |